PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. The company was founded on October 28, 1996 and is headquartered in Las Vegas, NV.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
2
Frequently Asked Questions
What is Market Cap of PharmaCyte Biotech Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. PharmaCyte Biotech Inc market cap is $7.07M.
What is the 52-week high for PharmaCyte Biotech Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. PharmaCyte Biotech Inc 52 week high is $2.42 as of September 15, 2025.
What is the 52-week low for PharmaCyte Biotech Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. PharmaCyte Biotech Inc 52 week low is $0.80 as of September 15, 2025.
What is PharmaCyte Biotech Inc stock price today?
PharmaCyte Biotech Inc stock price today is $1.04.
What was PharmaCyte Biotech Inc stock price yesterday?
PharmaCyte Biotech Inc stock price yesterday was $1.03.
What is the PE ratio of PharmaCyte Biotech Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. PharmaCyte Biotech Inc’s P/E ratio is 0.39.
What is the Price-to-Book ratio of PharmaCyte Biotech Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. PharmaCyte Biotech Inc P/B ratio is 0.1362.
What is the 50-day moving average of PharmaCyte Biotech Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. PharmaCyte Biotech Inc 50-day moving average is $0.9928.
How many employess does PharmaCyte Biotech Inc has?